12940928

Source:http://linkedlifedata.com/resource/pubmed/id/12940928

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:12940928	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:12940928	lifeskim:mentions	umls-concept:C0010346	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C0439849	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C1704632	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C0871261	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C0666743	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C2911692	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C1706817	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C0445223	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C1552599	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C1704787	lld:lifeskim
pubmed-article:12940928	lifeskim:mentions	umls-concept:C0872146	lld:lifeskim
pubmed-article:12940928	pubmed:issue	4	lld:pubmed
pubmed-article:12940928	pubmed:dateCreated	2003-8-27	lld:pubmed
pubmed-article:12940928	pubmed:abstractText	Infliximab is an effective therapy in adult patients with refractory and fistulizing Crohn's disease. Experience in children is still limited.	lld:pubmed
pubmed-article:12940928	pubmed:language	eng	lld:pubmed
pubmed-article:12940928	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12940928	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:12940928	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12940928	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12940928	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12940928	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:12940928	pubmed:month	Aug	lld:pubmed
pubmed-article:12940928	pubmed:issn	0269-2813	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:BarabinoAA	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:GuarisoGG	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:PapadatouBB	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:LionettiPP	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:MartelossiSS	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:BronziniFF	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:SalvestriniCC	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:BasciettoCC	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:CananiR...	lld:pubmed
pubmed-article:12940928	pubmed:author	pubmed-author:Dé AngelisG...	lld:pubmed
pubmed-article:12940928	pubmed:issnType	Print	lld:pubmed
pubmed-article:12940928	pubmed:day	15	lld:pubmed
pubmed-article:12940928	pubmed:volume	18	lld:pubmed
pubmed-article:12940928	pubmed:owner	NLM	lld:pubmed
pubmed-article:12940928	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:12940928	pubmed:pagination	425-31	lld:pubmed
pubmed-article:12940928	pubmed:dateRevised	2004-11-17	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:meshHeading	pubmed-meshheading:12940928...	lld:pubmed
pubmed-article:12940928	pubmed:year	2003	lld:pubmed
pubmed-article:12940928	pubmed:articleTitle	Response to infliximab is related to disease duration in paediatric Crohn's disease.	lld:pubmed
pubmed-article:12940928	pubmed:affiliation	Dipartimento di Pediatria, Università di Firenze-Ospedale Meyer, Florence, Italy.	lld:pubmed
pubmed-article:12940928	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:12940928	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:12940928	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:12940928	pubmed:publicationType	Multicenter Study	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12940928	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12940928	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12940928	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12940928	lld:pubmed